For press inquiries click here to contact us.
Science AAAS
Blood test shows promise for spotting early cancers
Forbes
Blueprint Medicines’ Cancer Drug Impresses In Early Study
FierceBiotech
6-month liver disease data reinforces CymaBay’s phase 3 move
FierceBiotech
Immunomedics poaches AstraZeneca I-O executive as new research chief
Bloomberg Markets
Novartis CEO Spurs Rare-Disease Shift With $8.7 Billion Deal
Boston 25 News
All women over 30 should consider breakthrough test, scientist says
Reuters
High-flying biotech Loxo tempers bullish view for cancer drug
TechCrunch
Color rolls out a test to try to search for hereditary risk for heart conditions like arrhythmia
Endpoints
The biotech IPO party rocks on with $120M raise for I/O player Arcus Biosciences
Please see important disclaimers in the Terms section.
